Stock Events

Stock Events

Regulus Therapeutics (RGLS) Q3 2023 Earnings

9NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.51

-0.46

-0.42

-0.37

Details

Expected EPS

-0.4

Actual EPS

-0.4

Surprise EPS

0

Surprise Percent

+0%

Description

Regulus Therapeutics (RGLS) has reported earnings of -0.4 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.